Who We Are Our Products Our Services Our Capabilities Careers News & Insights Contact search LinkedIn Youtube Home Who We Are Our acquisitions Our acquisitions Strategic acquisitions to fulfil our mission The consolidation of two businesses results in synergies that increase the value of both entities. Essentially, the value of a merged company exceeds the sum of the values of two individual organizations. In the last three years, we acquired three companies, sharing with us a strong commitment to improve patients lives and an innovative mindset, to always go the extra-mile to find new solutions. Thanks to these acquisitions, we are well on our way to achieve our vision of becoming the most patient-centric drug delivery device company worldwide. 2021: Milfra We acquired Milfra to establish an operational footprint in Brazil and expand our product and services offering to better serve the pharmaceutical industry in Latin America. Family-owned company founded in 1966, Milfra has specialized in the development and production of vaginal and rectal applicators, as well as oral dosers for the pharmaceutical industry. Milfra has been known for its expertise in high quality and high volume molding and assembly of devices and applicators. This strategic acquisition has expanded Nemera’s global footprint in Latin America, extending its product offering and providing a foundation for future contract manufacturing services; thereby reinforcing its overall commitment to serving local markets. By integrating a key applicator pure player, Nemera is now able to address specific patient and customer needs in the fields of gynecology and urology. Copernicus has become Nemera Jaguariúna and is today an integral part of our company. Discover more about our Oral, Vaginal, Rectal products 2020: Copernicus We acquired Copernicus to boost parenteral product portfolio and small series capabilities Founded in 2004, Copernicus has been known as one of the most valued innovative companies in the Polish health sector. They provide a comprehensive range of services in the introduction of modern and intuitive parenteral drug delivery devices. This acquisition has reinforced our vision of becoming the most patient-centric drug device combination solutions company, bolstering our small series production capabilities, R&D expertise and parenteral product offering. Most importantly it expanded our overall proprietary product portfolio. Copernicus’ fast and agile clinical manufacturing, adapted for small series, complemented Nemera’s historical large scale manufacturing capabilities. Copernicus has become Nemera Szczecin and is today an integral part of our company. Discover more about our pen injectors portfolio 2019: Insight We acquired Insight Product Development to strengthen our capabilities in early stage development and to reinforce client proximity in North America. For decades, Insight Product Development has delivered innovation in both medical and drug delivery devices services spanning the full development life cycle from early user research and human factors through to verification and design transfer. Insight has helped clients discover, innovate, and develop new product solutions through a user-centered design approach. The combination of both innovation organizations combined the strengths of Insight Product Development in front-end innovation, design research, human factors and design engineering with Nemera’s strong late-stage development, as well as clinical and commercial manufacturing capabilities. Insight Product Development is today an integral part of our “Insight Innovation Center”. Discover more about Insight Innovation Center Get in touch Get in touch to find out more about us, our solutions and what we can do for you. If you’re looking for job opportunities, please visit: Join Our Team First Name*: Last Name*: Company Name*: Job Title*: State: Country*: Please select... Afghanistan Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia Bosnia and Herzegowina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d'Ivoire Croatia (Hrvatska) Cuba Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic East Timor Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France France Metropolitan French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guinea Guinea-Bissau Guyana Haiti Heard and Mc Donald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran (Islamic Republic of) Iraq Ireland Israel Italy Jamaica Japan Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao, People's Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macau Macedonia, The Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands Netherlands Antilles New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Reunion Romania Russian Federation Rwanda Saint Kitts and Nevis Saint Lucia Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Seychelles Sierra Leone Singapore Slovakia (Slovak Republic) Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands Spain Sri Lanka St. Helena St. Pierre and Miquelon Sudan Suriname Svalbard and Jan Mayen Islands Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela Vietnam Virgin Islands (British) Virgin Islands (U.S.) Wallis and Futuna Islands Western Sahara Yemen Yugoslavia Zambia Zimbabwe Email*: Phone: Main Interest*: Please select... Our Services Our Products Other Channel (how did you hear about us?)*: Please select... Search Engine Social Media Website Exhibitions Press Word of Mouth Third party network Other Message*: Your personal data is intended for Nemera and its subsidiaries to process your request for information. You have rights over your personal data, such as the right to access, erase and object. For more information, see our Privacy Policy. * Required fields. LinkedIn Twitter Youtube Who We Are Privacy Policy Cookies policy Legal Policy 20 Avenue de la Gare 38290 La Verpillière - France T. +33 4 74 94 06 54 © 2021 Nemera. Website developed by Illustrate Digital